CN1911294A - Medicine for treating cervical spondylosis and lumba vertebrae disease - Google Patents
Medicine for treating cervical spondylosis and lumba vertebrae disease Download PDFInfo
- Publication number
- CN1911294A CN1911294A CN 200610048635 CN200610048635A CN1911294A CN 1911294 A CN1911294 A CN 1911294A CN 200610048635 CN200610048635 CN 200610048635 CN 200610048635 A CN200610048635 A CN 200610048635A CN 1911294 A CN1911294 A CN 1911294A
- Authority
- CN
- China
- Prior art keywords
- injection
- medicine
- milliliters
- examples
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of injection for treating cervical and lumbar intervertebral disc protrusion, and the hyperosteoplasia of cervical vertebra, lumbar vertebra and joints contains proportionally safflower injection, the injection of Chinese angelica root, the injection of red sage root, Shuang Huanglian injection and physiological saline.
Description
Technical field
The present invention relates to the medicine of a kind of non-operative treatment neck, lumbar spondylosis.
Background technology
Neck prolapse of lumbar intervertebral disc, hyperosteogeny belong to commonly encountered diseases, frequently-occurring disease, all ages more than 20 years old are inferior all can be taken place, the highest with the middle-aged and elderly people sickness rate, as treat the untimely neck lumbar vertebra deformity that causes, and along with the development of the state of an illness, cause intervertebral disk hernia to increase the weight of, spinal nucleus pulposus is splashed out and is increased, and spinal column forms complication such as inclined to one side song, hunchback.Also can occur carrying out property of neck flank pain in addition and increase the weight of, night, pain was more violent, and neck, waist bend and stretch functional disorder, occurred serious symptoms such as heavy burden and difficulty in walking then, directly influenced patient's work, studying and living.At present both at home and abroad the method for treatment neck prolapse of lumbar intervertebral disc has: 1, traditional tcm therapy, and promptly oral and outsourcing Chinese herbal medicine, it is with activating blood circulation to dissipate blood stasis, expelling wind and removing dampness, Shujin cold expelling, reducing swelling and alleviating pain are main; 2, the simple non-operation symptomatic treatment of doctor trained in Western medicine is the external application analgesic plaster etc. of advocating peace to take analgesic drug product; 3, doctor trained in Western medicine operative therapy; A, intervertebral disc as at cervical part of esophagus, might cause cervical region trunk and neural damage in the art when prolapse; As in the breast section, operation must so just might cause the damage and the postoperative hemopneumothorax of mediastinum internal organs in the thoracic cavity from the thoracic cavity approach, and sequela such as chest pain over a long time appears in pleural adhesion; As in the waist section, operation must be from the abdominal cavity approach, so just might cause in the thoracic cavity complication such as damage of trunk and postoperative intestinal adhesion behind the internal organs and peritoneum.B, intervertebral disc are when processus aboralis or pleurapophysis, and operation must be from the back approach, and this operation pathway is when operation, careless slightly, all might cause damage neural in spinal nerve root and the canalis spinalis, severe patient can cause the severe complication of postoperative quadriplegia or gatism, postoperative wound infection etc.; 4, injection fibrolysis enzyme treatment neck protrusion of lumbar vertebral disc when the medicine injection is inaccurate, as is injected at when vertebra is other to be organized, and can cause the histolysis machine to change into scleroma and aggravates the pain; As when being injected at intervertebral foramina, can causing the damage of spinal nerve root, thereby cause numb limbs and tense tendons or sensory disturbance; In the time of in medicine is strayed into canalis spinalis, the loss of nerve fiber in the canalis spinalis can be caused, the severe complication of quadriplegia may be occurred after the medication; 5, cervical lumbar vertebra traction therapy, the effect of this method mainly are the ligament around the neck lumbar vertebra body to be obtained certain elongation loosen, thereby but short time alleviating pain symptom; 6, caring massaging therapy, this method is by manual massage the soft tissues such as muscle ligament around the vertebral body to be played loosening of short time, physical therapy is the heat effect effect with TDP lamp, infrared ray radiation, local blood circulation amount is increased, thereby but short time alleviating pain symptom, but disadvantageous aspect is, cervical and lumbar diseases to osteoproliferation, under the physical action that maneuver is massaged stimulates, not only do not have therapeutical effect, also can quicken its outgrowth speed on the contrary.For a long time, observe through clinical case, no matter be oral in, Western medicine, still massage physical therapy, its recovery is all comparatively slow, the course of disease is grown, weak curative effect.If adopt operative therapy, then have a big risk, the medical expense height, general patient can't bear, and is simultaneously careless slightly, easily causes complication, sequela; When adopting the ocrase injection treatment, the danger that causes complication is arranged also.
Summary of the invention
The object of the present invention is to provide a kind of cure rate height, recover fast, relapse rate is low, and is safe, need not perform the operation, and expense is low, and is easy and simple to handle, with the medicine of controlling with the treatment cervical and lumbar diseases of walking.
The present invention is achieved in that a kind of medicine for the treatment of cervical and lumbar diseases without operation, it is characterized in that being furnished with in per 100 milliliters of medicinal liquids:
Flos Carthami injection 2-10 milliliter
Radix Angelicae Sinensis injection 5-12 milliliter
Radix Salviae Miltiorrhizae Injection 10-28 milliliter
SHUANGHUANGLIAN ZHUSHEYE 10-25 milliliter
The normal saline surplus.
Each raw material components of adapted of the present invention is the accurate word of traditional Chinese medicines commercially available prod.The novel drugs that cooperates the back to form has following major function:
Pharmacological action in the present invention's prescription: the Flos Carthami injection of choosing mainly plays activating blood circulation to dissipate blood stasis in prescription, Shujin detumescence, promoting of the circulation of QI and removing the obstruction in the collaterals, bone and muscle strengthening and inhibition and the effect of repairing outstanding intervertebral disc; Radix Angelicae Sinensis injection mainly plays blood circulation promoting and enriching, and the effect of outbalance is also played in the effect of silt detumescence, promoting of the circulation of QI and removing the obstruction in the collaterals and the inhibition vertebral body hyperosteogeny of loosing to neck, lumbar vertebra and the recovery in bones of limbs joint injury later stage; Radix Salviae Miltiorrhizae Injection mainly plays activating blood circulation to dissipate blood stasis, Repercusion analgesia, and promoting of the circulation of QI and removing the obstruction in the collaterals, the effect of softening microcirculatory vascular is also played in the effect of loose silt detumescence and expelling wind and removing dampness simultaneously in the part; SHUANGHUANGLIAN ZHUSHEYE mainly plays heat-clearing and toxic substances removing, expelling wind and removing dampness, cold expelling and the effect of Shujin repercussive; Normal saline different according to ages and state of an illness weight in prescription are mainly played the effect of coordinating the actions of various ingredients in a prescription.
The present invention has following advantage and effect: medicine provided by the invention, its main action and function is an activating blood circulation to dissipate blood stasis, relaxing muscles and tendons and removing obstructionfrom meridians, promoting the circulation of QI to relieve pain, reducing swelling and alleviating pain, reunion of bone, bone and muscle strengthening, expelling wind and cold, inducing diuresis and reducing edema, suppress neck, prolapse of lumbar intervertebral disc and bones of limbs hyperosteogeny are to neck, lumbar intervertebral disc outstanding, vertebral body hyperosteogeny and ligament injury play to be repaired and the effect that absorbs, be applicable to neck, outstanding and the bone matrix hyperplasia of lumbar intervertebral disc, and the neck that causes of a variety of causes, diseases such as the acute or chronic soft tissue injury of lumbar vertebra and extremity and lumbago, skelalgia of rheumatism.
Be the curative effect of the medicine that shows the present invention, the present invention is through 150 routine clinical observations, and its effect is as follows:
1, clinical data
1.1 physical data
All cases are the outpatient, totally 150 examples, and wherein, male's 95 examples account for 63%; Women's 55 examples account for 37%, and age-based section is divided: 15 examples in 20-30 year, account for 10%, and 45 examples in 30-50 year account for 90 examples more than 30%, 50 years old, account for 60%.Press the damage location branch: neck, prolapse of lumbar intervertebral disc and hyperosteogeny 123 examples account for 82%; Extremities joint hyperosteogeny 15 examples account for 10%; Neck, waist extremity soft tissue injury 12 examples account for 8%.
The present invention adopts open at random contrast packet design method, and whole patients are divided into treatment group and matched group.80 examples are organized in treatment, wherein male 50 examples, women 30 examples, matched group 70 examples, wherein male 45 examples, women 25 examples.Learn by statistics and handle, there not being significant difference (P＞0.05) aspect age, sex, the course of disease, have comparability between two groups.
1.2 diagnostic criteria
All patients all meet the diagnostic criteria of national regulation.Wherein treatment is organized in 80 examples, neck, prolapse of lumbar intervertebral disc patient's 45 examples, neck, lumbar vertebra hyperosteogeny patient 29 examples, patient's 6 examples of neck, waist soft tissue injury.
2, treatment and observational technique
2.1 Therapeutic Method
Treatment group: after medicine prepared, extract 3-8 milliliter/time/day, one course of treatment of 5-7 day,, medicinal liquid is injected at outstanding intervertebral disc position accurately at the both sides of pathological changes vertebral body inserting needle; To the patient of neck, lumbar vertebra hyperosteogeny disease, with the medicine direct injection at diseased region; To the patient of soft tissue injury, with the medicine direct injection in pathological tissues.
Matched group: use commercially available medicine for external use and subsidiary massage according to a conventional method, changed dressings once in per two days, 7-15 time is a course of treatment.
Test group and matched group are all followed up a case by regular visits to once with each outpatient service course of treatment, the relevant situation of itemized record.Treat 2-3 the course of treatment altogether, treatment is carried out therapeutic evaluation after finishing.
2.2 efficacy evaluation method
2.2.1 efficacy assessment standard:
Clinical recovery: take the photograph the sheet demonstration through X-light and CT-, outstanding intervertebral disc or hyperosteogeny have obtained repairing and absorbing.
Produce effects: take the photograph the sheet inspection through X-light and CT-, outstanding intervertebral disc or hyperosteogeny obviously obtain repairing and absorbing, and waist leg movements functional rehabilitation is normal.
Effectively: take the photograph the sheet inspection through X-light and CT-, outstanding intervertebral disc or hyperosteogeny make moderate progress, and local blood circulation is normal, and local swelling is disappeared.
Invalid: take the photograph the sheet inspection through X-light and CT-, outstanding intervertebral disc or hyperosteogeny are not improved, and waist shank pain is not alleviated.
3, therapeutic outcome
The treatment group is totally 80 examples, 72 examples of wherein fully recovering, and produce effects 5 examples, effective 2 examples, invalid 1 example, total effective rate is 98.75%.Matched group is totally 70 examples, 0 example of wherein fully recovering, and produce effects 10 examples, effective 38 examples, invalid 22 examples, total effective rate is that 68.57%, two group of result learns by statistics to handle significant difference, the clinical drug of the present invention matched group (P＜0.01) that is higher than evident in efficacy are arranged.
The specific embodiment
Below in conjunction with embodiment medicine of the present invention respectively being organized each components in proportions is described further:
Embodiment 1
The preparation of raw material of following ratio is become 100 milliliters of injection:
2 milliliters of Flos Carthami injections
5 milliliters of Radix Angelicae Sinensis injections
28 milliliters of Radix Salviae Miltiorrhizae Injectiones
25 milliliters of SHUANGHUANGLIAN ZHUSHEYE
40 milliliters of normal saline.
Usage: carry out closed injection in this ratio gradation at diseased region, the 5-8 milliliter/time/day, one course of treatment of 5-7 day.
Embodiment 2
The preparation of raw material of following ratio is become 100 milliliters of injection:
10 milliliters of Flos Carthami injections
12 milliliters of Radix Angelicae Sinensis injections
10 milliliters of Radix Salviae Miltiorrhizae Injectiones
10 milliliters of SHUANGHUANGLIAN ZHUSHEYE
58 milliliters of normal saline.
Usage: with embodiment 1.
Embodiment 3
The preparation of raw material of following ratio is become 100 milliliters of injection:
6 milliliters of Flos Carthami injections
8 milliliters of Radix Angelicae Sinensis injections
18 milliliters of Radix Salviae Miltiorrhizae Injectiones
20 milliliters of SHUANGHUANGLIAN ZHUSHEYE
48 milliliters of normal saline.
Usage: with embodiment 1.
Embodiment 4
8 milliliters of Flos Carthami injections
10 milliliters of Radix Angelicae Sinensis injections
15 milliliters of Radix Salviae Miltiorrhizae Injectiones
16 milliliters of SHUANGHUANGLIAN ZHUSHEYE
51 milliliters of normal saline.
Usage: with embodiment 1.
Claims (1)
1, a kind of medicine for the treatment of cervical and lumbar diseases without operation is characterized in that being furnished with in per 100 milliliters of medicinal liquids:
Flos Carthami injection 2-10 milliliter
Radix Angelicae Sinensis injection 5-12 milliliter
Radix Salviae Miltiorrhizae Injection 10-28 milliliter
SHUANGHUANGLIAN ZHUSHEYE 10-25 milliliter
The normal saline surplus.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610048635 CN1911294A (en) | 2006-08-23 | 2006-08-23 | Medicine for treating cervical spondylosis and lumba vertebrae disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610048635 CN1911294A (en) | 2006-08-23 | 2006-08-23 | Medicine for treating cervical spondylosis and lumba vertebrae disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1911294A true CN1911294A (en) | 2007-02-14 |
Family
ID=37720458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610048635 Pending CN1911294A (en) | 2006-08-23 | 2006-08-23 | Medicine for treating cervical spondylosis and lumba vertebrae disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1911294A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106913878A (en) * | 2017-03-24 | 2017-07-04 | 山西金源华康农业科技有限公司 | A kind of medicine for treating bone joint pain |
| CN107198712A (en) * | 2016-03-17 | 2017-09-26 | 李文华 | A kind of parenteral solution for treating the protrasion of the lumbar intervertebral disci |
| CN107625944A (en) * | 2017-09-29 | 2018-01-26 | 南京仙草堂生物科技有限公司 | Warm application of a kind of ginger folium artemisiae argyi cervical vertebra and preparation method thereof |
-
2006
- 2006-08-23 CN CN 200610048635 patent/CN1911294A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107198712A (en) * | 2016-03-17 | 2017-09-26 | 李文华 | A kind of parenteral solution for treating the protrasion of the lumbar intervertebral disci |
| CN106913878A (en) * | 2017-03-24 | 2017-07-04 | 山西金源华康农业科技有限公司 | A kind of medicine for treating bone joint pain |
| CN107625944A (en) * | 2017-09-29 | 2018-01-26 | 南京仙草堂生物科技有限公司 | Warm application of a kind of ginger folium artemisiae argyi cervical vertebra and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1118285C (en) | Shubi plaster for treating arthralgia due to wind-cold-dampness | |
| CN100376276C (en) | Soothe tendons and activating-blood anodyne plaster | |
| CN101062194A (en) | Medicine for treating bone disease and fracture and the preparing method thereof | |
| CN1911294A (en) | Medicine for treating cervical spondylosis and lumba vertebrae disease | |
| CN1872310A (en) | Preparation of Chinese traditional medicine for treating hyperosteogeny | |
| CN102274293A (en) | Muscle and bone relaxing capsules | |
| CN101474242B (en) | Medicament for treating cervical vertebra and lumbar vertebra diseases without operation | |
| CN100542583C (en) | A kind of pharmaceutical composition for the treatment of vertebra and arthropathy | |
| CN103585483B (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
| CN101530522B (en) | Chinese medicine preparation for treating wind-cold-dampness pains | |
| CN101057893A (en) | Traditional Chinese medicine for treating osteoproliferation, rheumatoid and rheumatic arthritis and sciatica | |
| CN1850257A (en) | Bone-setting powder | |
| CN1569199A (en) | Medicinal prescription for treating aseptic necrosis of femur head | |
| CN101214291B (en) | Externally-applied medicine for treating cervical and lumbar diseases without operation | |
| CN102614350A (en) | Chinese medicine for treating cervical spondylosis | |
| CN103157072B (en) | Chinese medicinal composition for treating cervical spondylosis | |
| CN102000235B (en) | Externally-applied health-care medicinal wine | |
| CN1315507C (en) | Externally applied ointment | |
| CN1899564A (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc | |
| CN1250268C (en) | Fumigant | |
| Qian et al. | Observation on Therapeutic Effect of Conservative Treatment with Acupuncture, Tui Na Combining with Chinese Herbal Fumigation to Treat Lumbar Disc Herniation. | |
| CN1611237A (en) | Musk tendon relaxation and joint rigidity relieving medicine | |
| CN104689176B (en) | A kind of Chinese medicine preparation for treating knee osteoarthritis and preparation method thereof | |
| CN112870281A (en) | A Chinese medicinal composition for treating rheumatic diseases, and preparation method of medicated liquor | |
| CN100404050C (en) | Traditional Chinese medicine wine for treating cervical, lumbar vertebrae extruded disk and spinal stenosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |